Barbara Gayle Duncan Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Barbara Gayle Duncan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Director in IMMUNOMEDICS INC ($IMMU) and Director in Innoviva, Inc. ($THRX) and CEO in Euthymics Bioscience Inc ($DOVP) and Director in Euthymics Bioscience Inc ($DOVP) and President and CFO in Euthymics Bioscience Inc ($DOVP) and Director in MEDGENICS, INC. ($MDGN) and Chief Accounting Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Atea Pharmaceuticals, Inc. ($AVIR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in Ovid Therapeutics Inc. ($OVID) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Fusion Pharmaceuticals Inc. ($FUSN).

Barbara Gayle Duncan in INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Barbara Gayle Duncan: Chief Accounting Officer, Chief Financial Officer
Holdings: 30,661 shares
Current Value: $3,482,170
Latest Transaction: Oct 05 2016
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Barbara Gayle Duncan in INTERCEPT PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADAP, GNMX, AVIR, DOVP, FUSN, IMMU, THRX, ICPT, JNCE, OVID

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 05 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Accounting Of ...SellS163.2014723,99030,66130.8 K to 30.7 K (-0.48 %)
Jul 07 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Accounting Of ...SellS145.1114621,18630,80831 K to 30.8 K (-0.47 %)
Apr 06 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS130.7614418,82930,94831.1 K to 30.9 K (-0.46 %)
Feb 12 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseA95.748,100775,4948,100
Feb 12 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...GrantA0.006,200031,09224.9 K to 31.1 K (+24.91 %)
Jan 05 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM0.001,29800
Jan 05 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS145.9042862,44724,89225.3 K to 24.9 K (-1.69 %)
Jan 05 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS145.90405,83625,32025.4 K to 25.3 K (-0.16 %)
Jan 05 2016ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM0.001,298025,36024.1 K to 25.4 K (+5.39 %)
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM0.001,29801,298
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM8.671,0008,6676,940
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseA161.1610,6001,708,29610,600
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS159.04548,58824,06224.1 K to 24.1 K (-0.22 %)
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS163.391,000163,39024,11625.1 K to 24.1 K (-3.98 %)
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM0.001,298025,11623.8 K to 25.1 K (+5.45 %)
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM8.671,0008,66723,81822.8 K to 23.8 K (+4.38 %)
Oct 05 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...GrantA0.004,050022,81818.8 K to 22.8 K (+21.58 %)
Jul 07 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM0.001,29802,596
Jul 07 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS239.00123918,76818.8 K to 18.8 K (-0.01 %)
Jul 07 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS238.16247618,76918.8 K to 18.8 K (-0.01 %)
Jul 07 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS236.135011,80718,77118.8 K to 18.8 K (-0.27 %)
Jul 07 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM0.001,298018,82117.5 K to 18.8 K (+7.41 %)
Jul 06 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM8.671,0008,6677,940
Jul 06 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS242.101,000242,10017,52318.5 K to 17.5 K (-5.40 %)
Jul 06 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM8.671,0008,66718,52317.5 K to 18.5 K (+5.71 %)
Apr 03 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...Option ExerciseM0.001,29803,894
Apr 03 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS277.703910,83017,52317.6 K to 17.5 K (-0.22 %)
Apr 03 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...BuyM0.001,298017,56216.3 K to 17.6 K (+7.98 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS293.3430088,00116,26416.6 K to 16.3 K (-1.81 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS292.1610029,21616,56416.7 K to 16.6 K (-0.60 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS291.0010029,10016,66416.8 K to 16.7 K (-0.60 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS289.0010028,90016,76416.9 K to 16.8 K (-0.59 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS288.0010028,80016,86417 K to 16.9 K (-0.59 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS287.0010028,70016,96417.1 K to 17 K (-0.59 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS286.0010028,60017,06417.2 K to 17.1 K (-0.58 %)
Apr 01 2015ICPTINTERCEPT PHARMACE ...Duncan Barbara GayleChief Financial Off ...SellS285.0010028,50017,16417.3 K to 17.2 K (-0.58 %)

Page:   1

Contact us | Follow us on Twitter